| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/29/2008 | CA2245484C Novel urea derivatives |
| 04/29/2008 | CA2244078C Use of leukotriene b4 or its analogues as antiviral and antineoplastic agents |
| 04/29/2008 | CA2218887C Piperazino derivatives as neurokinin antagonists |
| 04/29/2008 | CA2177952C Nucleosides and oligonucleotides containing boron clusters |
| 04/28/2008 | CA2666880A1 Organic compounds |
| 04/27/2008 | CA2608478A1 Skin disinfectant |
| 04/27/2008 | CA2586614A1 Triterpenes derivatives and uses thereof as antitumor agents or anti-inflammatory agents |
| 04/25/2008 | CA2602078A1 Acute and chronic heartburn composition and method |
| 04/24/2008 | WO2008049123A2 2,4-pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases |
| 04/24/2008 | WO2008049085A1 Antisense compounds |
| 04/24/2008 | WO2008049078A1 Nicked or gapped nucleic acid molecules and uses thereof |
| 04/24/2008 | WO2008049073A2 Compositions for the treatment of inflammation in the brain and other tissues |
| 04/24/2008 | WO2008049047A2 Quinoline compounds |
| 04/24/2008 | WO2008049043A2 Ophthalmic compositions comprising diglycine |
| 04/24/2008 | WO2008049042A2 Ophthalmic compositions containing diglycine |
| 04/24/2008 | WO2008049020A2 Diclofenac gel |
| 04/24/2008 | WO2008048981A2 Indole antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 04/24/2008 | WO2008048967A1 Tripodal cyclohexane derivatives and their use as carbohydrate receptors |
| 04/24/2008 | WO2008048957A1 Process for preparing oxymorphone, naltrexone, and buprenorphine |
| 04/24/2008 | WO2008048914A1 Polycyclic compounds which modulate the cb2 receptor |
| 04/24/2008 | WO2008048867A2 Bicyclic heteroaromatic compounds |
| 04/24/2008 | WO2008048866A2 Bicyclic heteroaromatic compounds |
| 04/24/2008 | WO2008048802A1 Phenylalkyl carbamate compositions |
| 04/24/2008 | WO2008048801A2 Phenylalkylamino carbamate compositions |
| 04/24/2008 | WO2008048770A1 Methods, compositions, and formulations for the treatment of thyroid eye disease |
| 04/24/2008 | WO2008048727A2 Wound dressings containing complexes of transition metals and alginate for elastase-sequestering |
| 04/24/2008 | WO2008048711A1 Process for preparing oxymorphone |
| 04/24/2008 | WO2008048668A2 Novel inhibitors of chymase |
| 04/24/2008 | WO2008048648A2 Cb1-modulating compounds and their use |
| 04/24/2008 | WO2008048636A2 Small molecule intervention for obesity |
| 04/24/2008 | WO2008048611A1 Process for the synthesis of individual isomers of mono-peg cci-779 |
| 04/24/2008 | WO2008048609A1 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| 04/24/2008 | WO2008048589A2 Compounds and methods for treatment of hcv |
| 04/24/2008 | WO2008048577A1 Methods of using 4-phenylaminoquinolines as topical non-steroidal antiinflammatory compounds |
| 04/24/2008 | WO2008048540A2 2-hydroxy-2-phenyl/thiophenyl propionamides as androgen receptor modulators |
| 04/24/2008 | WO2008048538A1 Hiv integrase inhibitors |
| 04/24/2008 | WO2008048503A2 Imidazole substitured pyrazole kinase inhibitors |
| 04/24/2008 | WO2008048502A1 Substituted pyrazole kinase inhibitors |
| 04/24/2008 | WO2008048493A2 Thermal management of very small form factor projectors with synthetic jets |
| 04/24/2008 | WO2008048461A2 Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion,or as a matrix for delivery of therapeutic components |
| 04/24/2008 | WO2008048375A1 Pyridonecarboxamide derivatives useful in treating hyper-proliferative and angiogenesis disorders |
| 04/24/2008 | WO2008048205A2 Method for delivering hydrophobic drugs via nanocrystal formulations |
| 04/24/2008 | WO2008048194A1 Use of the protein kinase c inhibitor tamoxifen for the treatment of bipolar disorder |
| 04/24/2008 | WO2008048171A1 N- (2 -hydroxyethyl) -n-methyl- 4- (quinolin- 8-yl (1- (thiazol-4- ylmethyl) piperidin- 4 -ylidene) methyl) benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression. |
| 04/24/2008 | WO2008048134A1 Pharmaceutical compositions for preventing and treating eye pathologies |
| 04/24/2008 | WO2008048085A1 Synergic pharmaceutical composition containing pentoxifylline, vitamin b6, vitamin b12 and folic acid |
| 04/24/2008 | WO2008048084A1 Pharmaceutical combinations for the treatment of dyslipidemia accompanied by high blood pressure |
| 04/24/2008 | WO2008048083A1 Pharmaceutical compositions for the treatment of thromboembolic diseases |
| 04/24/2008 | WO2008048076A1 A composition for treatment of atopic dermatitis comprising glucosamine and derivatives thereof and a method for treatment of atopic dermatitis using them |
| 04/24/2008 | WO2008048053A1 Pharmaceutical composition for prevention and treatment of parkinson's disease containing 1,2-di[2-methoxy-4-(2-carboxylvinyl)]phenoxyethane as an active ingredient |
| 04/24/2008 | WO2008048043A1 Use of sphingosylphosphorylcholine modulator for inhibiting expression of ccl27/ctack |
| 04/24/2008 | WO2008047983A1 Composition for preventing and treating inflammatory bowel diseases |
| 04/24/2008 | WO2008047952A2 Antidepressant, neuroprotectant, amyloid beta deposition inhibitor or age retardant containing heterocyclic compound |
| 04/24/2008 | WO2008047951A2 An alzheimer' s disease progression inhibitor containing heterocyclic compound |
| 04/24/2008 | WO2008047948A1 Block copolymer for drug complex and pharmaceutical composition |
| 04/24/2008 | WO2008047909A1 Novel method for production of 1-methylcarbapenem and novel intermediate |
| 04/24/2008 | WO2008047883A1 Piperazine-substituted benzothiophenes for treatment of mental disorders |
| 04/24/2008 | WO2008047880A1 Therapeutic agent for rheumatoid arthritis |
| 04/24/2008 | WO2008047863A1 Sustained release preparation for tissue regeneration therapy |
| 04/24/2008 | WO2008047857A1 METHOD OF PRODUCING COMPOSITION COMPRISING HARDLY WATER-SOLUBLE COMPOUND ENCLOSED IN HYDROPHILIC MATRIX AND PREPARATION FOR EXTERNAL USE COMPRISING ANTICANCER AGENT OR DRUG HAVING OCTANOL/WATER PARTITION COEFFICIENT (Log P) OF -3.0 OR MORE BUT NOT MORE THAN 3.0 ENCLOSED IN HYDROPHILIC BASE |
| 04/24/2008 | WO2008047853A1 Prophylactic/therapeutic agent for gastroesophageal reflux disease |
| 04/24/2008 | WO2008047839A1 5-ht1a receptor agonist |
| 04/24/2008 | WO2008047831A1 Jak inhibitor |
| 04/24/2008 | WO2008047821A1 Fused heterocyclic compound |
| 04/24/2008 | WO2008047819A1 Novel ester hydrolase, gene encoding the same, and use thereof |
| 04/24/2008 | WO2008047779A1 Therapeutic or prophylactic agent for atopic dermatitis |
| 04/24/2008 | WO2008047769A1 Glucose metabolism ameliorating agent |
| 04/24/2008 | WO2008047758A1 Antiinflammatory agent comprising 2-aminophenol or derivative thereof as active ingredient |
| 04/24/2008 | WO2008047709A1 Nk1 receptor antagonist composition |
| 04/24/2008 | WO2008047681A1 Benzimidazole compound having gastric acid secretion inhibitory activity |
| 04/24/2008 | WO2008047663A1 Activity enhancer for detoxifying enzyme |
| 04/24/2008 | WO2008047658A1 Animal feed additive and animal feed |
| 04/24/2008 | WO2008047633A1 Aliphatic compound-containing skin whitening agent |
| 04/24/2008 | WO2008047574A1 Sensitizer for anticancer agent |
| 04/24/2008 | WO2008047559A1 Highly water-dispersible powder and method of producing the same |
| 04/24/2008 | WO2008047544A1 Diaryl ketimine derivative |
| 04/24/2008 | WO2008047364A2 Method and pharmacological composition for the diagnosis and treatment of male sub-fertility |
| 04/24/2008 | WO2008047307A1 Pyrido [2, 3-d] pyrimidines and their use as kinase inhibitors |
| 04/24/2008 | WO2008047239A2 Stable aerosol pharmaceutical formulations |
| 04/24/2008 | WO2008047224A1 Pyrazolyl-4-oxy-benzonitrile derivatives useful in treating endometriosis |
| 04/24/2008 | WO2008047208A1 Pharmaceutical composition in the form of coated microspheres for the modified release of a muscle relaxant and an nsaid |
| 04/24/2008 | WO2008047201A2 Solid dispersion comprising a poorly water soluble drug |
| 04/24/2008 | WO2008047198A1 Therapeutic pyrazolyl thienopyridines |
| 04/24/2008 | WO2008047174A1 Alpha-galactosylceramide analogs, their methods of manufacture, intermediate compounds useful in these methods, and pharmaceutical compositions containing them |
| 04/24/2008 | WO2008047167A1 Polymorphs of o-desmethyl venlafaxine succinate |
| 04/24/2008 | WO2008047163A1 Buprenorphine-containing non-pressurised spray composition for transmucosal administration |
| 04/24/2008 | WO2008047149A1 Pharmaceutical compositions and nasal spray incorporating anhydrous mometasone furoate |
| 04/24/2008 | WO2008047109A1 Thiazole derivatives as kinase inhibitors |
| 04/24/2008 | WO2008047105A1 Crystalline form of benzothiophene compound and process for preparation thereof |
| 04/24/2008 | WO2008047082A2 Polymorphic form of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-one |
| 04/24/2008 | WO2008047067A1 Treatment of inflammatory disease |
| 04/24/2008 | WO2008046994A2 Novel composition and uses thereof, in particular cosmetic uses, for treating skin dehydration |
| 04/24/2008 | WO2008046982A2 New imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular cdc7 |
| 04/24/2008 | WO2008046919A2 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors |
| 04/24/2008 | WO2008046902A2 Compounds and methods for the modulation of toll-like receptor function |
| 04/24/2008 | WO2008046882A2 Composition comprising an nk-1 receptor antagonist and an ssri for the treatment of tinnitus and hearing loss |
| 04/24/2008 | WO2008046870A1 Long-term feed - cancer patient |
| 04/24/2008 | WO2008046860A2 Bioavailable combinations for hcv treatment |
| 04/24/2008 | WO2008046802A1 Phenylacetamides useful as protein kinase inhibitors |
| 04/24/2008 | WO2008046799A2 Preparation of granules of hydrophilic vitamins |